PEP Earnings 'Less Bad Than Expected,' 'Ozempic Effect' Cuts Into Profits

PepsiCo (PEP) rallied on today's earnings, with Alexis Browne Roberts noting a "surprisingly resilient" consumer lifting the numbers. However, she still wouldn't buy the stock even after today's report, giving the case that today's earnings were only "less bad" than it could have been. Dale Smothers still sees the stock as a strong dividend play. One bearish take he gives is America's Ozempic Effect" that will hit PepsiCo's snack profits.

Trading 360

17 Jul 2025

SHARE

Schwab Network's Newsletters

Daily insights for every investor